Clinical Trial Update: A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

This update indicates the Phase 1 study of CC-90010 in combination with temozolomide, with or without radiation therapy, for newly diagnosed glioblastoma has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CC-90010
• Temodar (Temozolomide)

Snippet

Sponsor: Celgene | Conditions: Glioblastoma | Phase 1 | Status: TERMINATED